Medicollect is proud to present Enroller, a truly innovative IT project the company has been involved in since late 2015.
Enroller is a software solution developed specifically for presenting elevated security level patient data to hospital personnel in a user friendly way.
As a screening tool, Enroller captures all data gathered throughout the screening process, providing a total picture of the patient at a glance for Medicollect staff as well as hospital personnel. Enroller not only speeds up the process of screening patients for clinical trials, it also improves the quality of the screening and elevates the level of security with which patients’ sensitive information is treated.
The project is sponsored by the Innovation Fund Denmark, and has been developed in close partnership with the Danish diabetes community, The Life With Diabetes.
For introduction to Enroller, please contact CEO Rene Ludwigs.
Medicollect’s competences on recruiting people with diabetes for clinical trials have been in great demand.
Based on clients’ requests Medicollect has decided to add Neurology as a core recruitment service. In UK Medicollect already has a client, Canbex Therapeutics, who is dedicated to treating spasticity in multiple sclerosis.
The company CEO, Rene Ludwigs agrees that it is a bold move:
“It’s clearly a very ambitious strategy to expand that quickly, but we have set the pace high because our clients are happy with our services. We are looking forward to working on other MS projects as well as projects focusing on Alzheimer’s and Parkinson. “
So far, companies such as Novartis, GSK, and the international CRO, Pharm-Olam, have shown interest in using Medicollect’s recruitment services within neurology as well.